Dihydroartemisinin Synergistically Promotes the Antileukemic Activity of Venetoclax By Downregulating Mcl-1 in Acute Myeloid Leukemia Cells

被引：0
|
作者：
Zhuang, Haihui [1 ]
Chen, Yao [1 ]
Li, Fenglin [1 ]
Jin, Jie [2 ]
Lu, Ying [3 ]
机构：
[1] Ningbo Univ, Dept Hematol, Affiliated Peoples Hosp, Ningbo, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[3] Yinzhou Peoples Hosp, Dept Hematol, Ningbo, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184408
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Mcl-1 Dependence Predicts Response To Vorinostat and Gemtuzumab Ozogamicin In Acute Myeloid Leukemia
    Pierceall, William E.
    Lena, Ryan
    Medeiros, Bruno C.
    Estey, Elihu H.
    Blake, Noel
    Elaschoff, Michael
    Cardone, Michael
    Walter, Roland B.
    BLOOD, 2013, 122 (21)
  • [22] Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia
    Pierceall, William E.
    Lena, Ryan J.
    Medeiros, Bruno C.
    Blake, Noel
    Doykan, Camille
    Elashoff, Michael
    Cardone, Michael H.
    Walter, Roland B.
    LEUKEMIA RESEARCH, 2014, 38 (05) : 564 - 568
  • [23] Myeloid Cell Leukemia-1 (MCL-1) siRNA Therapy Showed Cytotoxic Effect on T Cells Acute Lymphoblastic Leukemia
    Askarian-Amiri, Shaghayegh
    Aval, Farzane Ordoni
    Azadmehr, Abbas
    Oladnabi, Morteza
    Vesiehsari, Mahjoobeh Jafari
    Hajiahmadi, Mahmoud
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2019, 12 (04)
  • [24] Opposing Mcl-1, the GALIG proapoptotic gene is upregulated as neutrophils die and underexpressed in Acute Myeloid Leukemia cells
    Mollet, Lucile
    Robinet, Pauline
    Dubois, Martine
    Aurouet, Axel
    Normand, Thierry
    Charpentier, Stephane
    Sureau, Adelin
    Grandclement, Camille
    Garnache-Ottou, Francine
    Deconinck, Eric
    Brule, Fabienne
    Rohrlich, Pierre Simon
    Legrand, Alain
    MOLECULAR IMMUNOLOGY, 2013, 56 (1-2) : 123 - 128
  • [25] Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
    Zhang, Qi
    Riley-Gillis, Bridget
    Han, Lina
    Jia, Yanan
    Lodi, Alessia
    Zhang, Haijiao
    Ganesan, Saravanan
    Pan, Rongqing
    Konoplev, Sergej N.
    Sweeney, Shannon R.
    Ryan, Jeremy A.
    Jitkova, Yulia
    Dunner, Kenneth, Jr.
    Grosskurth, Shaun E.
    Vijay, Priyanka
    Ghosh, Sujana
    Lu, Charles
    Ma, Wencai
    Kurtz, Stephen
    Ruvolo, Vivian R.
    Ma, Helen
    Weng, Connie C.
    Ramage, Cassandra L.
    Baran, Natalia
    Shi, Ce
    Cai, Tianyu
    Davis, Richard Eric
    Battula, Venkata L.
    Mi, Yingchang
    Wang, Jing
    DiNardo, Courtney D.
    Andreeff, Michael
    Tyner, Jeffery W.
    Schimmer, Aaron
    Letai, Anthony
    Padua, Rose Ann
    Bueso-Ramos, Carlos E.
    Tiziani, Stefano
    Leverson, Joel
    Popovic, Relja
    Konopleva, Marina
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [26] Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1
    Janssen, Maike
    Schmidt, Christina
    Bruch, Peter-Martin
    Blank, Maximilian F.
    Rohde, Christian
    Waclawiczek, Alexander
    Heid, Daniel
    Renders, Simon
    Goellner, Stefanie
    Vierbaum, Lisa
    Besenbeck, Birgit
    Herbst, Sophie A.
    Knoll, Mareike
    Kolb, Carolin
    Przybylla, Adriana
    Weidenauer, Katharina
    Ludwig, Anne Kathrin
    Fabre, Margarete
    Gu, Muxin
    Schlenk, Richard F.
    Stoelzel, Friedrich
    Bornhaeuser, Martin
    Roellig, Christoph
    Platzbecker, Uwe
    Baldus, Claudia
    Serve, Hubert
    Sauer, Tim
    Raffel, Simon
    Pabst, Caroline
    Vassiliou, George
    Vick, Binje
    Jeremias, Irmela
    Trumpp, Andreas
    Krijgsveld, Jeroen
    Mueller-Tidow, Carsten
    Dietrich, Sascha
    BLOOD, 2022, 140 (24) : 2594 - 2610
  • [27] Palbociclib promotes the antitumor activity of Venetoclax plus Azacitidine against acute myeloid leukemia
    Wang, Anyou
    Fang, Mingmeng
    Jiang, Hui
    Wang, Dongyao
    Zhang, Xuhan
    Tang, Baolin
    Zhu, Xiaoyu
    Hu, Wanglai
    Liu, Xin
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [28] The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia
    Li, Xinyu
    Su, Yongwei
    Hege, Katie
    Madlambayan, Gerard
    Edwards, Holly
    Knight, Tristan
    Polin, Lisa
    Kushner, Juiwanna
    Dzinic, Sijana H.
    White, Kathryn
    Yang, Jay
    Miller, Regan
    Wang, Guan
    Zhao, Lijing
    Wang, Yue
    Lin, Hai
    Taub, Jeffrey W.
    Ge, Yubin
    HAEMATOLOGICA, 2021, 106 (05) : 1262 - 1277
  • [29] Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner
    Huang, Shujuan
    Li, Chenying
    Zhang, Xiang
    Pan, Jiajia
    Li, Fenglin
    Lv, Yunfei
    Huang, Jingwen
    Ling, Qing
    Ye, Wenle
    Mao, Shihui
    Huang, Xin
    Jin, Jie
    MOLECULAR ONCOLOGY, 2020, 14 (10) : 2560 - 2573
  • [30] Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia
    Meunier, Godelieve
    Birsen, Rudy
    Cazelles, Clarisse
    Belhadj, Maya
    Cantero-Aguilar, Lilia
    Kosmider, Olivier
    Fontenay, Michaela
    Azar, Nabih
    Mayeux, Patrick
    Chapuis, Nicolas
    Tamburini, Jerome
    Bouscary, Didier
    ONCOGENESIS, 2020, 9 (10)
12345